On 22 August, Navy OJAG’s Code 20 sent out this Brady notice as a result of a false positive reported by Navy Drug Screening Laboratory San Diego.  The lab improperly reported a blind proficiency sampe as positive for amphetamines, MDMA, and MDA when it was expected that the sample would be positive only for MDMA and MDA.  As a result, in April the San Diego lab was temporarily suspended from reporting drug test results.

And don’t forget the June 2009 false positive that the Air Force Drug Testing Laboratory actually reported to an innocent Airman’s unit.

2 Responses to “Brady notice for Navy Drug Screening Laboratory false positive”

  1. stacy says:

    This is a bad mistake. There should be a better process in place to prevent this from happening.
    I work for a calibration lab and we have to abide by ISO requirement and would hate for this to happen.

  2. Dew_Process says:

    While styled as a Brady notice, it is more of a deflection than disclosure.  They could have saved a lot of litigation time and expense by disclosing how the false positive occurred, e.g., human error vs. machine; why the so-called “internal review” process didn’t catch it immediately; and what corrective action is now (versus then) in place.

    Mistakes happen in all professions, but when you testify under oath about the “fail safe” technology [or the current BS “raw data”] and redundant safeguards, you are now proving that it is a lie.

    Melendez-Diaz and Blazier have been vindicated.